Links
Tools
Comparison of efficacy and safety of two available natural surfactants in Iran, Curosurf and Survanta in treatment of neonatal respiratory distress syndrome: A randomized clinical trial
Journal article published in 2016 by
Bita Najafian,
Hamidreza Karimi-Sari,
Mohammad Hossein Khosravi 
,
Niloofar Nikjoo,
Sobhan Amin,
Majid Shohrati
,
Niloofar Nikjoo,
Sobhan Amin,
Majid Shohrati
Abstract
The benefit of surfactant prescription for respiratory distress syndrome (RDS) has been approved. Curosurf and Survanta are two commonly used natural surfactants in Iran. Previous studies did not report priority for one of these two drugs. The present study aimed to compare the effectiveness and safety of Curosurf and Survanta in treatment of RDS.